Heterogeneous response patterns of alveolar macrophages from patients with lung cancer by stimulation with interferon-γ

Japanese Journal of Clinical Oncology

Volumn 30, Issue 7, 2000, Pages 295-300

  Eifuku, Ryozo ^a   Yoshimatsu, Takashi ^a   Yoshino, Ichiro ^a   Takenoyama, Mitsuhiro ^a   Imahayashi, Satoru ^a   So, Tomoko ^a   Hanagiri, Takeshi ^a   Nomoto, Kikuo ^b   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Alveolar macrophages; Interferon ; Lung cancer; Nitric oxide; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ARTICLE; CELL LINE; CELL STIMULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG INHIBITION; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MACROPHAGE ACTIVATION; MALE; TREATMENT OUTCOME;

ADENOCARCINOMA; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-1BETA; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MALE; NITRIC OXIDE; PEPTIDE FRAGMENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033818560     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. The role of macrophages in defense against neoplastic disease
2. Role of tumor-associated macrophages in lung cancer
3. Antitumor activity of macrophages in lung cancer patients with special reference to location of macrophages
4. Role of antitumor activity of alveoler macrophages in lung cancer patients
5. Antitumor activity of pleural cavity macrophages and its regulation by pleural cavity lymphocytes in patients with lung cancer
6. The cell biology of macrophage activation
7. Comparison of transforming growth factor-beta and a macrophage-deactivating polypeptide from tumor cells. Differences in antigenicity and mechanism of action
8. Deactivation of macrophages by transforming growth factor-beta
9. Tumor necrosis factor: A potent effector molecule for tumor cell killing by activated macrophages
10. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor cells
11. Cytotoxic activity of human pulmonary alveolar macrophages
12. Human bronchoalveolar macrophage cytotoxicity for cultured human lung-tumor cells
13. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway
14. The role of tumor necrosis factor in cachexia
15. Interleukin 1, tumor necrosis factor and the pathogenesis of cancer cachexia
16. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
17. T helper subsets require the expression of distinct costimulatory signals by antigen-presenting cells
18. Macrophage induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses
19. Cytotoxic mechanism of tumor necrosis factor-α
20. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide
21. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: Comparison of activating cytokines and evidence for independent production
22. Hydrogen peroxide release from mouse peritoneal macrophages. Dependence on sequential activation and triggering
23. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-α production
24. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: A new approach to cancer immunotherapy